[unable to retrieve full-text content]

The likes of Pfizer and Lilly have announced the halting of research in light of Moscow’s offensive against Ukraine Several major international pharmaceutical companies including Pfizer, Lilly and Sanofi have issued statements, announcing the suspension of new clinical trials in Russia in light of its military campaign against Ukraine.

The central bank had previously hiked rates at five successive meetings over a six-month period Russia’s central bank left its key interest rate unaltered at 16% at its scheduled meeting on Friday, saying that tight monetary policy will be necessary to return stubborn inflation back to target levels.